Accent Capital Management »

iShares Dow Jones US Pharm Indx shares owned by Accent Capital Management

Quarter-by-quarter ownership of iShares Dow Jones US Pharm Indx (IHE) shares owned by Accent Capital Management from 13F filings

Historical chart of Accent Capital Management investment in iShares Dow Jones US Pharm Indx

Tip: Access up to 7 years of quarterly data

All positions including iShares Dow Jones US Pharm Indx held by Accent Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares Dow Jones US Pharm Indx by Accent Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $42k 500 84.83

More positions owned by Accent Capital Management

ALPHABET INC Class A Cl A Com (GOOG)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Inc A Cl A Com (META)
Amazon (AMZN)
Spdr S&p 500 Etf (SPY)
Vanguard S&p 500 Etf idx (VOO)
Vanguard Growth ETF (VUG)
Eli Lilly & Co. (LLY)
Costco Wholesale Corporation (COST)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Broadcom (AVGO)
VISA INC Class A Cl A Com (V)

View all positions for Accent Capital Management

Top funds holding iShares Dow Jones US Pharm Indx

Fisher Investments
Foundations Investment Advisors
LPL Financial
Anfield Capital Management
Jpmorgan Chase & Co
Royal Bank of Canada
Bnp Paribas Arbitrage, Snc
Goldman Sachs Group
Brown Advisory Holdings Incorporated
Accurate Wealth Management
Raymond James Financial
Prevail Innovative Wealth Advisors
Wells Fargo & Company
Concord Investment Counsel
Advisor Group Holdings

View all funds holding iShares Dow Jones US Pharm Indx